These stocks offer growth at a reasonable price as the second quarter kicks off
[ad_1] While stocks have enjoyed a strong start to 2024, CNBC Pro found that there are still plenty of opportunities…
2024-07-03 12:10:45
[ad_1] While stocks have enjoyed a strong start to 2024, CNBC Pro found that there are still plenty of opportunities…
[ad_1] Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug —…
[ad_1] (This is CNBC Pro’s live coverage of Monday’s analyst calls and Wall Street chatter. Please refresh every 20-30 minutes…
[ad_1] Check out the companies making headlines in midday trading. Meta Platforms — The Facebook and Instagram parent soared 20%…
[ad_1] Signage is displayed on a Humana Inc. office building in Louisville, Kentucky, U.S., on Sunday, Feb. 3, 2019. Humana…
[ad_1] Sopa Images | Lightrocket | Getty Images Eli Lilly is shaking up the pharmaceutical industry with a new website…
[ad_1] An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. David…
[ad_1] Sopa Images | Lightrocket | Getty Images Shares of Cigna jumped Monday following reports that the health-care giant has…
[ad_1] The Cigna Group headquarters in Bloomfield, Connecticut, US, on Friday, Oct. 27, 2023. BlooJoe Buglewicz | Bloomberg | Getty…
[ad_1] The FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to Ozempic and Wegovy. Courtesy: Eli Lilly Eli…